Skip links

Great News: Cyto-Facto Becomes Official Partner of BatchLine in Japan

BatchLine, who provides digital solutions of groundbreaking cloud EBR that simplify and streamline operations is thrilled to announce that Cyto-Facto, a leading provider in the field of cell and gene therapy is not only our highly valued customer but also our official partnership.

This collaboration marks a significant milestone in advancing the health and well-being of patients who need cutting-edge cell and gene therapies.
 

 
(Left) Dave Margetts, CEO at BatchLine
(Right) Shin Kawamata, CEO at Cyto Facto
 
 
Further information, please contact us or email directly to info@batchline.com

 
 
(Left) David Holt, Managing Director at BatchLine
(Right) Dave Margetts, CEO at BatchLine

Subscribe for regular updates and news.

Leave a comment

This website uses cookies to improve your web experience.